June 30, 2014 — Clinicians at Froedtert & the Medical College of Wisconsin Clinical Cancer Center are achieving excellent planning results in the first U.S. combination of Elekta's Monaco 5 radiotherapy treatment planning software and Siemens' mARC (modulated arc) therapy technique. The Froedtert & the Medical College team treated their first patient, an individual with prostate cancer, using the combination of Monaco 5 and mARC on March 26.

"mARC is a form of volumetric modulated arc therapy [VMAT], which has significant advantages over step-and-shoot IMRT in radiotherapy delivery speed and/or dose conformity, so we were eager to get mARC working on our Siemens treatment machine," said X. Allen Li, Ph.D., chief physicist, department of radiation oncology at Froedtert & the Medical College of Wisconsin Clinical Cancer Center. "The first case was a complex two-arc plan for treating both pelvic nodes and prostate bed, but on pre-treatment verification we achieved 99 percent agreement between the measured dose distribution and the plan dose distribution, which is very good. And, we've been able to replicate this accuracy in most of cases measured so far."

Li added that the two-arc treatment took eight minutes to deliver, faster than conventional step-and-shoot IMRT delivery. Furthermore, the cancer center plans to add flattening filter-free (FFF) beams in this summer, which will significantly speed up mARC delivery. 

"Planning mARC delivery with Monaco 5 is straightforward," stated Li. "From the dosimetrist's standpoint, there is not much difference planning between mARC and other delivery techniques, so in a sense, workflow is identical. Having multiple treatment methods in Monaco 5 is a significant improvement over previous versions and the Monaco 5 contouring tools are excellent — we can contour using multi-modality images, such as those from CT, MRI and PET. I also really like the biological-based optimization, which gives us more flexibility in terms of shaping the dose distribution."

Introduced last year, the latest version of Monaco 5 consolidates the best of Elekta's treatment planning solutions into a single, comprehensive system. A vendor-neutral solution, Monaco 5 allows advanced treatment plans to be created faster and features a completely new user interface. As in all Monaco releases, this new version employs the Monte Carlo dose engine, considered the gold standard for calculating radiation dose.

For more information: www.elekta.com, www.froedtert.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now